(Q43948597)

28 November 2017

title

Anisylazoformylarginine: a superior assay substrate for carboxypeptidase B type enzymes (English)

1 reference

28 November 2017

William L Mock

1

1 reference

28 November 2017

Daniel J Stanford

series ordinal

2

1 reference

28 November 2017

language of work or name

English

0 references

publication date

1 April 2002

1 reference

Bioorganic & Medicinal Chemistry Letters

28 November 2017

published in

1 reference

28 November 2017

volume

12

1 reference

28 November 2017

issue

8

1 reference

28 November 2017

page(s)

1193-1194

1 reference

Arazoformyl dipeptide substrates for thermolysin. Confirmation of a reverse protonation catalytic mechanism

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900128-2

7 January 2021

Arazoformyl peptide surrogates as spectrophotometric kinetic assay substrates for carboxypeptidase A

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900128-2

7 January 2021

Catalytic activity of carboxypeptidase B and of carboxypeptidase Y with anisylazoformyl substrates

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900128-2

7 January 2021

Human nasal mucosal carboxypeptidase: activity, location, and release

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900128-2

7 January 2021

Both cellular and soluble forms of thrombomodulin inhibit fibrinolysis by potentiating the activation of thrombin-activable fibrinolysis inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900128-2

7 January 2021

A study of the mechanism of inhibition of fibrinolysis by activated thrombin-activable fibrinolysis inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2802%2900128-2

7 January 2021

10.1016/S0960-894X(02)00128-2

Identifiers

DOI

1 reference

28 November 2017

1 reference